Cardiology_Hypertension

Chest Pain, Palpitations, Seizure in an Elderly WomanPatient has a history of hypertension; symptoms present x1 day; what's your read of the ECG?
SPRINT Trials: Update From ASHWill more aggressive BP control reduce the risk of CV outcomes? Finally, some answers.
Hypertension 2-case QuizResistant hypertension? A hypertensive emergency? Select your strategy and then find out if the evidence supports it.
App Review: The ACC-AHA ASCVD Risk Estimator
App Review: The ACC-AHA ASCVD Risk EstimatorThe practice of CVD risk estimation shifted radically in 2013. The ACC-AHA app helps you connect the new dots.
ACC 2016 – Full of Snow and ScienceOur cardiologist blogger highlights PARTNER-2, HOPE-3, and sessions on women in cardiology at ACC.16.
6 Cardiology Meeting HighlightsResearchers presented several new findings about statins and non-statins at ACC.16. This brief roundup summarizes these and other noteworthy reports.
CardioScience Update, 4 New StudiesHighlights of four recent studies in hypertension, heart failure, preeclampsia expose vulnerable populations.
A Hypertension Quiz in 3 CasesFind out what you know about how to avoid therapeutic inertia in treatment of hypertension.
Time to Retire Beta-Blockers in Uncomplicated Hypertension
Time to Retire Beta-Blockers in Uncomplicated HypertensionBeta-blockers were one of the first modern medications used for the treatment of blood pressure. Before 1950, treatment options for hypertension were limited. The alphabet soup of medications -- reserpine, pentaquine, hydralazine, and guanethidine -- were notorious for inducing orthostasis, sedation, constipation, impotence, or blurry vision.
Testosterone Tx Gives Weak Signal for Cardiovascular RiskThere is no compelling evidence that testosterone therapy increases or decreases cardiovascular risk, according to a new position statement from the American Academy of Clinical Endocrinologists (AACE). The statement was issued in response to recent publications that have raised concern that testosterone replacement therapy (TRT) increases cardiovascular risks in men and media reports about the dangers of testosterone therapy.